Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms

NCT07316088 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Oui Therapeutics, Inc.

Collaborators